First Manhattan Co
- SEC CIK
- 0000728083
- Latest filing
- Aug 14, 2026
SABS holding history
SAB Biotherapeutics, Inc. in every 13F filed by First Manhattan Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
SABS overviewAll 13F holders of SABSFull Q2 2026 holdings
- Shares (Q4 2024)
- 0
- Sold out in Q4 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q1 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2024 | 0 | $0 | 0.0% | −24,577−100.0% | Sold out | Holders |
| Q3 2024 | 24,577 | $66.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 24,577 | $76.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 24,577 | $111.6K | <0.1% | −3,201−11.5% | ReducedConverted for a 1-for-10 split | Holders |
| Q4 2023 | 277,777 | $191.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 277,777 | $175.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 277,777 | $230.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 277,777 | $122.2K | <0.1% | +277,777 | New | Holders |